VEDA.LAB currently supplies over 120 high-quality diagnostic products to over 80 countries worldwide.

VEDA.LAB has a number of new products in the pipeline such as products for Chagas, Lyme disease, dengue fever. The company commits itself to provide the highest quality and most innovative immunodiagnostic products.

As a recognized world leader in the field of rapid point-of-care diagnostics, VEDA.LAB has established a reputation for high quality, performance and innovation. Professionals in physicians' offices, laboratories and clinics around the world place their trust in VEDA.LAB's products for their diagnostic testing requirements. VEDA.LAB currently markets its products in over 80 countries. The trademarks: "New test generation", "Diagnostics for the future", "Baby Check", "Baby Check Plus", "Evidence","Evidence2" and Easy Reader, are marketed through local and international distributors and retailers, and through partnerships with leading pharmaceutical and medical diagnostic companies.

VEDA.LAB provides excellent support to its distributors worldwide.

The main advantages are:

• Quality
• Fast and efficient services
• Competitive pricing